\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ specific\\ findings\\ noted\\.\\ possibly\\ enlarged\\ and\\ irregular\\ uterus\\ on\\ bimanual\\ exam\\.\ \(0\)\
\-\ depending\\ on\\ the\\ patient\\'s\\ symptoms\\,\\ surgical\\ options\\ may\\ be\\ discussed\\.\ \(0\)\
\-\ numerous\\ areas\\ of\\ discrete\\ low\\ signal\\ intensity\\ in\\ the\\ muscle\\ of\\ the\\ uterus\\ and\\ below\\ the\\ serosa\\.\\ uterus\\ is\\ irregularly\\ enlarged\\.\ \(0\)\
\-\ uterine\\ leiomyoma\ \(5\)\
\-\ adenomyosis\ \(10\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ endometrial\\ polyps\ \(2\)\
\-\ endometrial\\ cancer\ \(5\)\
\-\ patient\\ referred\\ by\\ ob\\-gyn\\ for\\ pelvic\\ mri\\.\\ no\\ symptoms\\ noted\\.\ \(0\)\
\-\ lesions\\/condition\\:\\ uterine\\ leiomyoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ smooth\\ muscle\\ cells\\ of\\ uterus\\ \ \(0\)\
\-\ synonyms\\:\\ fibroids\\ \ \(0\)\
\-\ associations\\/predisposing\\ factors\\:\\ increase\\ estrogen\\ states\\,\\ pregnancy\\,\\ african\\ american\\,\\ obesity\\,\\ perimenopausal\\ \ \(0\)\
\-\ common\\ locations\\:\\ uterus\\;\\ submucosal\\,\\ intramural\\,\\ subserosal\\ \ \(0\)\
\-\ demographics\\:\\ about\\ 25\\%\\ of\\ american\\ women\\ and\\ about\\ 40\\%\\ of\\ african\\ american\\ women\\ by\\ age\\ 40\\.\\ \ \(0\)\
\-\ gross\\ morphology\\:\\ smooth\\ muscle\\ tissue\\ \ \(0\)\
\-\ histology\\:\\ smooth\\ muscle\\ tissue\\ with\\ a\\ pseudocapsule\\ \ \(0\)\
\-\ radiology\\:\\ ultrasound\\ shows\\ areas\\ of\\ hyperechogenicity\\ and\\ an\\ enlarged\\ uterus\\.\\ mri\\ shows\\ discrete\\ areas\\ of\\ low\\ signal\\ intensity\\ and\\ an\\ irregularly\\ enlarged\\ uterus\\.\\ \ \(0\)\
\-\ treatment\\:\\ usually\\ expectant\\ management\\.\\ if\\ symptomatic\\,\\ treated\\ with\\ medications\\ to\\ decrease\\ estrogen\\ \\(provera\\,\\ danazol\\,\\ gnrh\\ agonists\\)\\,\\ uterine\\ artery\\ embolization\\,\\ myomectomy\\,\\ endometrial\\ ablation\\,\\ or\\ hysterectomy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uterus\\:\\ 0\\.4254093424792787\ \(0\)\
\-\ endometrial\\:\\ 0\\.21231429206642766\ \(0\)\
\-\ muscle\\:\\ 0\\.1967898186537297\ \(0\)\
\-\ uterine\\:\\ 0\\.1941078213681566\ \(0\)\
\-\ enlarged\\:\\ 0\\.18893202900459707\ \(0\)\
\-\ american\\:\\ 0\\.17734171220025674\ \(0\)\
\-\ estrogen\\:\\ 0\\.17265954450902538\ \(0\)\
\-\ smooth\\:\\ 0\\.1716141400708063\ \(0\)\
\-\ irregularly\\:\\ 0\\.15664502712201933\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.1439031812202105\ \(0\)\
\-\ discrete\\:\\ 0\\.14341241329786786\ \(0\)\
\-\ areas\\:\\ 0\\.14112062423001565\ \(0\)\
\-\ african\\:\\ 0\\.12515887396462896\ \(0\)\
\-\ women\\:\\ 0\\.12470480119416559\ \(0\)\
\-\ provera\\:\\ 0\\.11080297165229734\ \(0\)\
\-\ danazol\\:\\ 0\\.11080297165229734\ \(0\)\
\-\ myomectomy\\:\\ 0\\.11080297165229734\ \(0\)\
\-\ of\\:\\ 0\\.10847129121428101\ \(0\)\
\-\ perimenopausal\\:\\ 0\\.1058781547561944\ \(0\)\
\-\ gnrh\\:\\ 0\\.1058781547561944\ \(0\)\
\-\ about\\:\\ 0\\.10373952202042479\ \(0\)\
\-\ hyperechogenicity\\:\\ 0\\.10238394156057092\ \(0\)\
\-\ 40\\:\\ 0\\.10191218068581742\ \(0\)\
\-\ serosa\\:\\ 0\\.09967361924234207\ \(0\)\
\-\ intensity\\:\\ 0\\.09839490932686484\ \(0\)\
\-\ synonyms\\:\\ 0\\.09558679617706452\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.09558679617706452\ \(0\)\
\-\ expectant\\:\\ 0\\.09558679617706452\ \(0\)\
\-\ agonists\\:\\ 0\\.09558679617706452\ \(0\)\
\-\ subserosal\\:\\ 0\\.0939649114688445\ \(0\)\
\-\ demographics\\:\\ 0\\.08632977225451269\ \(0\)\
\-\ bimanual\\:\\ 0\\.08554588137711808\ \(0\)\
\-\ shows\\:\\ 0\\.08132946352755767\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.08062106448101512\ \(0\)\
\-\ low\\:\\ 0\\.0795130582152504\ \(0\)\
\-\ signal\\:\\ 0\\.07855222505197812\ \(0\)\
\-\ fibroids\\:\\ 0\\.07832251356100967\ \(0\)\
\-\ intramural\\:\\ 0\\.07712685128539165\ \(0\)\
\-\ obesity\\:\\ 0\\.07675309585861714\ \(0\)\
\-\ submucosal\\:\\ 0\\.07675309585861714\ \(0\)\
\-\ symptoms\\:\\ 0\\.07581845727695746\ \(0\)\
\-\ ablation\\:\\ 0\\.07569624758491218\ \(0\)\
\-\ polyps\\:\\ 0\\.07472404141654489\ \(0\)\
\-\ morphology\\:\\ 0\\.07382391909750871\ \(0\)\
\-\ histology\\:\\ 0\\.07353811548851232\ \(0\)\
\-\ noted\\:\\ 0\\.07347038905862148\ \(0\)\
\-\ tissue\\:\\ 0\\.07269146838528437\ \(0\)\
\-\ locations\\:\\ 0\\.07245775105458162\ \(0\)\
\-\ and\\:\\ 0\\.07158524298181498\ \(0\)\
\-\ mri\\:\\ 0\\.07113029584994139\ \(0\)\
\-\ discussed\\:\\ 0\\.06870782119366523\ \(0\)\
\-\ depending\\:\\ 0\\.06599749887543636\ \(0\)\
\-\ possibly\\:\\ 0\\.06511908539678589\ \(0\)\
\-\ options\\:\\ 0\\.06246538832313227\ \(0\)\
\-\ gross\\:\\ 0\\.061484453377556814\ \(0\)\
\-\ states\\:\\ 0\\.06087191554122996\ \(0\)\
\-\ embolization\\:\\ 0\\.06038405506450125\ \(0\)\
\-\ origin\\:\\ 0\\.059642078278853934\ \(0\)\
\-\ decrease\\:\\ 0\\.059552438809544306\ \(0\)\
\-\ by\\:\\ 0\\.05884548179865828\ \(0\)\
\-\ factors\\:\\ 0\\.05860774362227588\ \(0\)\
\-\ numerous\\:\\ 0\\.0585253969138953\ \(0\)\
\-\ medications\\:\\ 0\\.05812183510906482\ \(0\)\
\-\ below\\:\\ 0\\.057058373117275164\ \(0\)\
\-\ pregnancy\\:\\ 0\\.05670005530505946\ \(0\)\
\-\ increase\\:\\ 0\\.05561969087112878\ \(0\)\
\-\ radiology\\:\\ 0\\.055491159587461494\ \(0\)\
\-\ the\\:\\ 0\\.05530005763419181\ \(0\)\
\-\ pelvic\\:\\ 0\\.05416040689058806\ \(0\)\
\-\ irregular\\:\\ 0\\.053491645718432394\ \(0\)\
\-\ cells\\:\\ 0\\.05338367973676439\ \(0\)\
\-\ symptomatic\\:\\ 0\\.0532766650095874\ \(0\)\
\-\ an\\:\\ 0\\.05298926394710305\ \(0\)\
\-\ specific\\:\\ 0\\.052502766804876894\ \(0\)\
\-\ referred\\:\\ 0\\.05126811722942231\ \(0\)\
\-\ management\\:\\ 0\\.05117814575904765\ \(0\)\
\-\ 25\\:\\ 0\\.04908376185550526\ \(0\)\
\-\ cancer\\:\\ 0\\.04614919760574677\ \(0\)\
\-\ patient\\:\\ 0\\.04507034186672886\ \(0\)\
\-\ no\\:\\ 0\\.045061864398164425\ \(0\)\
\-\ usually\\:\\ 0\\.043617936411976296\ \(0\)\
\-\ age\\:\\ 0\\.043498269503486064\ \(0\)\
\-\ treated\\:\\ 0\\.04314618418587172\ \(0\)\
\-\ artery\\:\\ 0\\.04303105448063277\ \(0\)\
\-\ ultrasound\\:\\ 0\\.042736726549530236\ \(0\)\
\-\ on\\:\\ 0\\.04185096166491242\ \(0\)\
\-\ if\\:\\ 0\\.04025673302996297\ \(0\)\
\-\ cell\\:\\ 0\\.03963463181105461\ \(0\)\
\-\ common\\:\\ 0\\.03929294703036441\ \(0\)\
\-\ exam\\:\\ 0\\.03487847297365619\ \(0\)\
\-\ may\\:\\ 0\\.0348667658951957\ \(0\)\
\-\ findings\\:\\ 0\\.03419528862142793\ \(0\)\
\-\ surgical\\:\\ 0\\.03367512665517812\ \(0\)\
\-\ treatment\\:\\ 0\\.033004471355461126\ \(0\)\
\-\ be\\:\\ 0\\.02810645224841366\ \(0\)\
\-\ with\\:\\ 0\\.027134025696233566\ \(0\)\
\-\ or\\:\\ 0\\.024103273008189468\ \(0\)\
\-\ for\\:\\ 0\\.020999974123074732\ \(0\)\
\-\ is\\:\\ 0\\.018974368887442333\ \(0\)\
\-\ to\\:\\ 0\\.017321297314147024\ \(0\)\
\-\ in\\:\\ 0\\.01723604192464043\ \(0\)\
